Vitiligo following intravitreal ranibizumab : An association or an unrelated event ?

@inproceedings{Yadav2017VitiligoFI,
  title={Vitiligo following intravitreal ranibizumab : An association or an unrelated event ?},
  author={Ankur Kumar Yadav and Vishal Katiyar and Komal D. Singh and Vinita Singh},
  year={2017}
}
Age-related macular degeneration (ARMD) is the most common cause for visual impairment in the elderly in western countries. Its incidence in India is expected to increase with the increase in the size of geriatric population. Recently several antivascular endothelial growth factor (VEGF) drugs like pegaptanib sodium (Macugen), ranibizumab (Lucentis) and… CONTINUE READING